Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Hu, Guo Wen ^a,b   Li, Qing ^a   Niu, Xin ^a   Hu, Bin ^a   Liu, Juan ^a   Zhou, Shu Min ^a   Guo, Shang Chun ^a   Lang, Hai Li ^b   Zhang, Chang Qing ^a   Wang, Yang ^a   Deng, Zhi Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; MEMBRANE ANTIGEN;

ADIPOGENESIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMORAL ARTERY; FLOW CYTOMETRY; HINDLIMB; HUMAN; HUMAN CELL; IN VITRO STUDY; INCISION; ISOLATION PROCEDURE; LIMB INJURY; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PERFUSION; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL CULTURE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAFILTRATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; CELL MOTION; CYTOLOGY; INDUCED PLURIPOTENT STEM CELL; ISCHEMIA; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

IPS; MUS;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; EXOSOMES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ISCHEMIA; MESENCHYMAL STROMAL CELLS; MICE;

EID: 84938929476     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt546     Document Type: Article

References (53)

1. Miyajima A, Tanaka M, Itoh T: Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell 2014, 14: 561-74. 10.1016/j.stem.2014.04.010
2. Volarevic V, Bojic S: Stem cells as new agents for the treatment of infertility: current and future perspectives and challenges. Biomed Res Int 2014, 2014: 507234.
3. Abdelwahid E, Siminiak T, Guarita-Souza LC, de Carvalho KA T, Gallo P, Shim W, et al.: Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr Cardiol Rev 2011, 7: 201-12. 10.2174/157340311798220502
4. Choi SH, Jung SY, Kwon SM, Baek SH: Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges. Circ J 2012, 76: 1307-12. 10.1253/circj.CJ-11-1479
5. Gutierrez-Fernandez M, Rodriguez-Frutos B, Ramos-Cejudo J, Otero-Ortega L, Fuentes B, Diez-Tejedor E: Stem cells for brain repair and recovery after stroke. Expert Opin Biol Ther 2013, 13: 1479-83. 10.1517/14712598.2013.824420
6. van Velthoven CT, Sheldon RA, Kavelaars A, Derugin N, Vexler ZS, Willemen HL, et al.: Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 2013, 44: 1426-32. 10.1161/STROKEAHA.111.000326
7. Gremmels H, Fledderus JO, Teraa M, Verhaar MC: Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective. Stem Cell Res Ther 2013, 4: 140. 10.1186/scrt351
8. Lee EJ, Park HW, Jeon HJ, Kim HS, Chang MS: Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia. Regenerative Med 2013, 8: 283-93. 10.2217/rme.13.17
9. Boyle AJ, McNiece IK, Hare JM: Mesenchymal stem cell therapy for cardiac repair. Methods Mol Biol 2010, 660: 65-84. 10.1007/978-1-60761-705-1-5
10. Griffin MD, Ritter T, Mahon BP: Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010, 21: 1641-55. 10.1089/hum.2010.156
11. Xin Y, Wang YM, Zhang H, Li J, Wang W, Wei YJ, et al.: Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. Artif Organs 2010, 34: 215-22. 10.1111/j.1525-1594.2009.00824.x
12. Zaim M, Karaman S, Cetin G, Isik S: Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann Hematol 2012, 91: 1175-86. 10.1007/s00277-012-1438-x
13. Hirschi KK, Li S, Roy K: Induced pluripotent stem cells for regenerative medicine. Annu Rev Biomed Eng 2014, 16: 277-94. 10.1146/annurev-bioeng-071813-105108
14. Diederichs S, Tuan RS: Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev 2014, 23: 1594-610. 10.1089/scd.2013.0477
15. Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y, et al.: Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010, 121: 1113-23. 10.1161/CIRCULATIONAHA.109.898312
16. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, et al.: Spontaneous human adult stem cell transformation. Cancer Res 2005, 65: 3035-9.
17. Jeong JO, Han JW, Kim JM, Cho HJ, Park C, Lee N, et al.: Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circulation Res 2011, 108: 1340-7. 10.1161/CIRCRESAHA.110.239848
18. Ratajczak MZ, Jadczyk T, Pedziwiatr D, Wojakowski W: New advances in stem cell research: practical implications for regenerative medicine. Pol Arch Med Wewn 2014, 124: 417-26.
19. Thery C, Zitvogel L, Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2: 569-79.
20. Record M, Carayon K, Poirot M, Silvente-Poirot S: Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta 2014, 1841: 108-20. 10.1016/j.bbalip.2013.10.004
21. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor EN, et al.: Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 2013, 10: 301-12. 10.1016/j.scr.2013.01.002
22. Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H: Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 2014, 92: 387-97. 10.1007/s00109-013-1110-5
23. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M: Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 2013, 33: 1711-5. 10.1038/jcbfm.2013.152
24. Lai RC, Yeo RW, Tan KH, Lim SK: Exosomes for drug delivery - a novel application for the mesenchymal stem cell. Biotechnol Adv 2013, 31: 543-51. 10.1016/j.biotechadv.2012.08.008
25. Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, et al.: Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res 2008, 18: 600-3. 10.1038/cr.2008.51
26. Cai J, Li W, Su H, Qin D, Yang J, Zhu F, et al.: Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 2010, 285: 11227-34. 10.1074/jbc.M109.086389
27. Rowland TJ, Miller LM, Blaschke AJ, Doss EL, Bonham AJ, Hikita ST, et al.: Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev 2010, 19: 1231-40. 10.1089/scd.2009.0328
28. Zou L, Luo Y, Chen M, Wang G, Ding M, Petersen CC, et al.: A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Sci Rep 2013, 3: 2243.
29. Siow RC: Culture of human endothelial cells from umbilical veins. Methods Mol Biol 2012, 806: 265-74. 10.1007/978-1-61779-367-7-18
30. Kosaka N, Yoshioka Y, Hagiwara K, Tominaga N, Ochiya T: Functional analysis of exosomal microRNA in cell-cell communication research. Methods Mol Biol 2013, 1024: 1-10. 10.1007/978-1-62703-453-1-1
31. Montecalvo A, Larregina AT, Morelli AE: Methods of analysis of dendritic cell-derived exosome-shuttle microRNA and its horizontal propagation between dendritic cells. Methods Mol Biol 2013, 1024: 19-40. 10.1007/978-1-62703-453-1-3
32. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Madrid F, Mittelbrunn M: Analysis of microRNA and protein transfer by exosomes during an immune synapse. Methods Mol Biol 2013, 1024: 41-51. 10.1007/978-1-62703-453-1-4
33. Properzi F, Logozzi M, Fais S: Exosomes: the future of biomarkers in medicine. Biomark Med 2013, 7: 769-78. 10.2217/bmm.13.63
34. Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A, et al.: Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 2003, 108: 205-10. 10.1161/01.CIR.0000079225.50817.71
35. Ke N, Wang X, Xu X, Abassi YA: The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol 2011, 740: 33-43. 10.1007/978-1-61779-108-6-6
36. Zeng Y, Sun HR, Yu C, Lai Y, Liu XJ, Wu J, et al.: CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration. Cytokine 2011, 53: 42-51. 10.1016/j.cyto.2010.09.007
37. Li H, Chang J: Stimulation of proangiogenesis by calcium silicate bioactive ceramic. Acta biomaterialia 2013, 9: 5379-89. 10.1016/j.actbio.2012.10.019
38. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, et al.: Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 2009, 106: 14022-7. 10.1073/pnas.0903201106
39. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, et al.: Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007, 133: 717-25. 10.1016/j.jtcvs.2006.08.077
40. Ko IK, Kim BS: Mesenchymal stem cells for treatment of myocardial infarction. Int J Stem Cells 2008, 1: 49-54. 10.15283/ijsc.2008.1.1.49
41. Yang Z, Zhu L, Li F, Wang J, Wan H, Pan Y: Bone marrow stromal cells as a therapeutic treatment for ischemic stroke. Neurosci Bull 2014, 30: 524-34. 10.1007/s12264-013-1431-y
42. Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, et al.: Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341: 651-4. 10.1126/science.1239278
43. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126: 663-76. 10.1016/j.cell.2006.07.024
44. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318: 1917-20. 10.1126/science.1151526
45. Kwon HM, Hur SM, Park KY, Kim CK, Kim YM, Kim HS, et al.: Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis. Vasc Pharmacol 2014, 63: 19-28. 10.1016/j.vph.2014.06.004
46. Camussi G, Deregibus MC, Cantaluppi V: Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans 2013, 41: 283-7. 10.1042/BST20120192
47. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L: Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010, 78: 838-48. 10.1038/ki.2010.278
48. Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, et al.: Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics 2012, 2012: 971907.
49. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK: Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010, 38: 215-24. 10.1093/nar/gkp857
50. Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH: Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood 2014, 124: 3748-57. 10.1182/blood-2014-05-576116
51. Tadokoro H, Umezu T, Ohyashiki K, Hirano T, Ohyashiki JH: Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem 2013, 288: 34343-51. 10.1074/jbc.M113.480822
52. Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE, et al.: New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010, 116: 2385-94. 10.1182/blood-2009-08-239228
53. Richardson TP, Peters MC, Ennett AB, Mooney DJ: Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19: 1029-34. 10.1038/nbt1101-1029